South Korea's multicentre cooperative trials group, linking the Seoul mega-hospitals and regional centres in investigator-initiated trials in gastric, lung, liver and breast cancer.
Founded in 1998 by Korean medical oncologists, KCSG is the country's academic cooperative group and a founding member of the Asian Clinical Trials Network. It runs disease-specific committees (gastrointestinal, thoracic, breast, hepatobiliary, genitourinary, lymphoma, head and neck) and a data centre, and it is the route by which Korea's high-volume hospitals run multicentre investigator-initiated trials and correlative biomarker studies. Korean investigators enrol a large share of global gastric and EGFR-mutant lung cancer trials, and KCSG trials of second-line gastric chemotherapy and of precision oncology umbrella designs (K-MASTER) have been influential. Members include Seoul National University Hospital, Asan Medical Center, Samsung Medical Center and Severance.
Medical oncologist serving as 14th President of the Korean Cancer Study Group, Korea's main academic cooperative trials group.
Myung-Ju Ahn is one of Asia's most prolific lung cancer trialists, a steady presence on the steering committees of the EGFR, ALK, and immunotherapy trials that set today's standards.
Shares HER2-positive breast cancer, Gastric & gastro-oesophageal junction cancer, Small-molecule kinase inhibitors, Colorectal cancer and the tag cooperative-group.
Shares Hepatocellular carcinoma, Gastric & gastro-oesophageal junction cancer, Colorectal cancer and the tag cooperative-group.
Shares Comprehensive genomic profiling, Small-molecule kinase inhibitors, Non-small-cell lung cancer and the tag cooperative-group.
Shares HER2-positive breast cancer, Colorectal cancer and the tag cooperative-group.
Shares HER2-positive breast cancer, Colorectal cancer and the tag cooperative-group.
Shares Gastric & gastro-oesophageal junction cancer, Colorectal cancer and the tag cooperative-group.
Shares HER2-positive breast cancer, Non-small-cell lung cancer and the tag cooperative-group.
Shares HER2-positive breast cancer and the tag cooperative-group.